Insulin aspart, recombinant Subcutaneous and Nesiritide Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nesiritide Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nesiritide
Brand name: Natrecor
Synonyms: Nesiritide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Nestabs ABC
- Insulin aspart, recombinant Subcutaneous-Nestabs DHA Prenatal
- Insulin aspart, recombinant Subcutaneous-Nestabs One
- Insulin aspart, recombinant Subcutaneous-Nestabs Prenatal
- Insulin aspart, recombinant Subcutaneous-Netarsudil and Latanoprost
- Insulin aspart, recombinant Subcutaneous-Netspot
- Nesiritide Intravenous-Insulin degludec
- Nesiritide Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Nesiritide Intravenous-Insulin Degludec (U-100) Vials
- Nesiritide Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Nesiritide Intravenous-Insulin degludec and liraglutide
- Nesiritide Intravenous-Insulin degludec and liraglutide Subcutaneous